Moderna Therapeutics logo

Moderna Therapeutics

A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.

11

Funding Rounds

$2.7b

Money raised

Overview

A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.

Funding

Funding series

Funding Series Analysis

The company Moderna Therapeutics has raised a total of $1.73b in funding over 11 rounds.

Key Insights:

  • Moderna Therapeutics Grant (money), July 26, 2020: $472m
  • Moderna Therapeutics Grant (money), April 17, 2020: $483m
  • Moderna Therapeutics Series H round, May 3, 2018: $125m
  • Moderna Therapeutics Grant (money), January 12, 2016: $20m
  • Moderna Therapeutics Series E round, January 5, 2015: $450m
  • Moderna Therapeutics Corporate funding round, January 14, 2014: $25m
  • Moderna Therapeutics funding round, November 2013: $110m
  • Moderna Therapeutics funding round, December 2012: $40m
  • Moderna Therapeutics funding round, February 2018: $500m
  • Moderna Therapeutics Grant (money), September 2016: $8m
  • Moderna Therapeutics Series F round, August 2016: $474m
Moderna Therapeutics logo
Moderna Therapeutics Grant (money), July 26, 2020 $472m
Moderna Therapeutics logo
Moderna Therapeutics Grant (money), April 17, 2020 $483m
Moderna Therapeutics logo
Moderna Therapeutics Series H round, May 3, 2018 $125m
Moderna Therapeutics logo
Moderna Therapeutics Grant (money), January 12, 2016 $20m
Moderna Therapeutics logo
Moderna Therapeutics Series E round, January 5, 2015 $450m
Moderna Therapeutics logo
Moderna Therapeutics Corporate funding round, January 14, 2014 $25m
Moderna Therapeutics logo
Moderna Therapeutics funding round, November 2013 $110m
Moderna Therapeutics logo
Moderna Therapeutics funding round, December 2012 $40m
Moderna Therapeutics logo
Moderna Therapeutics funding round, February 2018 $500m
Moderna Therapeutics logo
Moderna Therapeutics Grant (money), September 2016 $8m
Moderna Therapeutics logo
Moderna Therapeutics Series F round, August 2016 $474m